Severe pneumonitis refractory to steroids following anti-PD-1 immunotherapy

Anti-programmed death 1 (PD-1) immune checkpoint inhibitors enhance the antitumour activity of the immune system and have produced durable tumour responses in several solid tumours including non-small cell lung cancer (NSCLC). However, PD-1 inhibitors can lead to immune-related adverse events, inclu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Case Rep
Main Authors: Andruska, Neal, Mahapatra, Lily, Hebbard, Carleigh, Patel, Priyank, Paul, Vishesh
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2018
Assuntos:
Unexpected Outcome (Positive or Negative) Including Adverse Drug Reactions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6194409/
https://ncbi.nlm.nih.gov/pubmed/30301729
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-225937
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados